Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 3 points (0.0%) at 16,165 as of Thursday, Dec. 19, 2013, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,090 issues advancing vs. 1,843 declining with 148 unchanged. The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.2%. On the negative front, top decliners within the industry include Insulet Corporation ( PODD), down 4.2%, DexCom ( DXCM), down 4.0%, Community Health Systems ( CYH), down 2.3%, Tenet Healthcare ( THC), down 2.1% and Universal Health Services ( UHS), down 1.7%. TheStreet would like to highlight 5 stocks pushing the industry lower today: 5. Intuitive Surgical ( ISRG) is one of the companies pushing the Health Services industry lower today. As of noon trading, Intuitive Surgical is down $3.79 (-1.1%) to $357.45 on light volume. Thus far, 113,081 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 471,700 shares. The stock has ranged in price between $355.25-$359.62 after having opened the day at $359.41 as compared to the previous trading day's close of $361.24. Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $13.5 billion and is part of the health care sector. The company has a P/E ratio of 21.3, above the S&P 500 P/E ratio of 17.7. Shares are down 27.4% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Intuitive Surgical a buy, 4 analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Intuitive Surgical as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow. Get the full Intuitive Surgical Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.